May 23, 2019
FDA grants Stryker premarket approval for intracranial aneurysm stent
Editor's Note
Stryker announced on May 20 that the Food & Drug Administration (FDA) granted premarket approval for its Neuroform Atlas stent system for intracranial aneurysms, the May 20 MassDevice reports.
The self-expanding nitinol stent can now be used with neurovascular embolization coils to treat patients with saccular wide-necked intracranial aneurysms that arise from a 2 mm to 4.5 mm parent vessel.
Free Daily News
- Simulation-based training boosts scrub nurses’ confidence in OR non-technical skills
- New AHRQ toolkit empowers OR teams to cut MRSA, SSI risk
- Study: Long working hours alter brain regions tied to emotion, cognition
- Survey: Burnout, rigid schedules push nurses to leave
- UCLA surgeons perform world’s first bladder transplant
- AHA urges HHS to cut regulations that burden hospitals and staff
- Commentary: Overlooking, underfunding perioperative mental health threatens patients
- Study: Fewer men undergo unnecessary prostate cancer surgery amid rise in active surveillance
- OpenAI benchmarking tool tests healthcare LLMs
- Healthgrades recognizes top 15% of hospitals for patient experience in 2025
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement